MedPath

Lisinopril

Lisinopril Tablets USP

Approved
Approval ID

6490cffe-28e5-434a-9ff0-81cd37cc9f31

Product Type

HUMAN PRESCRIPTION DRUG LABEL

Effective Date

Jun 16, 2011

Manufacturers
FDA

Legacy Pharmaceutical Packaging

DUNS: 143213275

Products 1

Detailed information about drug products covered under this FDA approval, including NDC codes, dosage forms, ingredients, and administration routes.

Lisinopril

Product Details

FDA regulatory identification and product classification information

FDA Identifiers
NDC Product Code68645-272
Application NumberANDA076059
Product Classification
M
Marketing Category
C73584
G
Generic Name
Lisinopril
Product Specifications
Route of AdministrationORAL
Effective DateJune 16, 2011
FDA Product Classification

INGREDIENTS (7)

FD&C YELLOW NO. 5Inactive
Code: I753WB2F1M
Classification: IACT
ANHYDROUS DIBASIC CALCIUM PHOSPHATEInactive
Code: L11K75P92J
Classification: IACT
LISINOPRILActive
Quantity: 20 mg in 1 1
Code: E7199S1YWR
Classification: ACTIB
MAGNESIUM STEARATEInactive
Code: 70097M6I30
Classification: IACT
MANNITOLInactive
Code: 3OWL53L36A
Classification: IACT
STARCH, CORNInactive
Code: O8232NY3SJ
Classification: IACT
COLLOIDAL SILICON DIOXIDEInactive
Code: ETJ7Z6XBU4
Classification: IACT

MedPath

Empowering clinical research with data-driven insights and AI-powered tools.

© 2025 MedPath, Inc. All rights reserved.

Lisinopril - FDA Drug Approval Details